volume 12, issue 4, Pe0174447 2017
DOI: 10.1371/journal.pone.0174447
View full text
|
Sign up to set email alerts
|
Share

Abstract: BackgroundStromal derived factor-1α (SDF-1α/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemia applied remote from the heart that protects the heat from lethal ischaemia-reperfusion injury. Accordingly, there is considerable interest in SDF-1α as a potential biomarker of such conditions. However, SDF-1α is rapidly degraded and …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
6
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals